RetractedArticleBioMed research international2022

Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.

Mengxiang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.